GlassScriptPrepare for your visit
Daniel J Curhan
Urology · Santa Barbara, CA · NPI 1760491112
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$14,931.88
in general payments reported to CMS, 2019-2025 · $853 in 2025
The $853 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Who reported paying
General payments only, top 6 by amount.
- Astellas Pharma US INC $7,447.18
- Boston Scientific Corporation $1,042.73
- Teleflex LLC $712.40
- Coloplast Corp $574.02
- Valencia Technologies Corporation $553.41
- Procept Biorobotics Corporation $368.77
Drugs and devices associated with these payments
Urolift Ams 700 Aquabeam Robotic System Signia Speedicath Spaceoar Vue System - 10ml Botox Adstiladrin Ams Ambicor Xtandi Gemtesa Anktiva
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Daniel Curhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/352971/daniel-j-curhan